Farmax India Annual Reports, Balance Sheet and Financials

Farmax India Limited Balance Sheet (Rs In Lakhs)

 Farmax India Limited Profit & Loss Statement (Rs In Lakhs)

Farmax India Limited Consolidated Cash Flow Statement (Rs In Lakhs)

Here 's an explanation of the Cash Flow Statement for the years 2016 and 2015, broken down into points:

Cash Flows from Operating Activities:

Profit / (Loss) before tax for the year:

In 2016, there was a loss of Rs. 982.64 lakhs, compared to a loss of Rs. 1738.93 lakhs in 2015.

Adjustments for Depreciation and Amortisation:

Depreciation and amortization expenses were Rs. 159.65 lakhs in 2016 and Rs. 216.63 lakhs in 2015.

Finance cost on Account of Term Loan:

Finance costs related to term loans amounted to Rs. 0.66 lakhs in 2016 and Rs. 6.01 lakhs in 2015.

Other Income:

Other income included a negative amount of Rs. 28.57 lakhs in 2016 and Rs. 178.42 lakhs in 2015.

Operating profit before working capital changes:

After considering the adjustments, the operating profit before working capital changes was Rs. -850.91 lakhs in 2016 and Rs. -1694.71 lakhs in 2015.

Changes in Working Capital:

There were changes in trade and other receivables, inventories, other current assets, and trade and other payables, contributing to the cash generated from operating activities.

Cash generated from Operating Activities:

Overall, cash generated from operating activities amounted to Rs. -41.28 lakhs in 2016 and Rs. -3267.15 lakhs in 2015.

Cash Flows from Investing Activities:

Purchase and Disposal of Fixed Assets:

Investments in fixed assets amounted to Rs. 91.56 lakhs in 2016 and Rs. -19.14 lakhs in 2015.

Increase/decrease in Fixed Investments- Other Non Current Assets:

There was an increase in fixed investments of Rs. 1.82 lakhs in 2016 and a decrease of Rs. 3.67 lakhs in 2015.

Other Income:

Other income included positive amounts of Rs. 28.57 lakhs in both 2016 and 2015.

Net Cash flow from investing activities:

Overall, net cash flow from investing activities amounted to Rs. 121.95 lakhs in 2016 and Rs. 155.61 lakhs in 2015.

Cash Flows from Financing Activities:

Proceeds from Issue of Share Capital:

No proceeds were received from the issue of share capital in 2016, whereas Rs. 1661.50 lakhs were received in 2015.

Proceeds from Borrowings (Increase in Borrowings):

There was a decrease in borrowings of Rs. 31.05 lakhs in 2016 and Rs. 49.07 lakhs in 2015.

Repayment of Term Loans:

Term loans were repaid amounting to Rs. 28.5 lakhs in 2016 and Rs. 2.72 lakhs in 2015.

Interest Paid:

Interest paid on loans amounted to Rs. 0.66 lakhs in 2016 and Rs. 6.01 lakhs in 2015.

Net Cash flow from financing activities:

Overall, net cash flow from financing activities amounted to Rs. -3.21 lakhs in 2016 and Rs. 1609.14 lakhs in 2015.

Net Cash flow during the year:

Overall, there was a net cash inflow of Rs. 77.46 lakhs in 2016 and a net cash outflow of Rs. -1502.40 lakhs in 2015.

Cash and Cash Equivalents:

Cash and cash equivalents at the beginning of the period were Rs. 23.61 lakhs in 2016 and Rs. 1.42 lakhs in 2015.

Cash and cash equivalents at the end of the period were Rs. 101.07 lakhs in 2016 and Rs. -1500.98 lakhs in 2015.

Farmax India Limited Financial Ratios

Here is a summary of the financial and operational metrics for Farmax India Limited for the years 2016 and 2015:

Current Ratio:

In 2016, the current ratio was 0.24, indicating a decrease in the company 's short-term liquidity compared to 2015 when it was 0.44.

Debt to Equity Ratio:

The debt to equity ratio was -2.53 in 2016 and -6.43 in 2015. A negative debt to equity ratio suggests that the company has more equity than debt.

Inventory Turnover Ratio:

The inventory turnover ratio increased from 2.38 in 2015 to 8.47 in 2016, indicating that the company efficiently managed its inventory turnover during the year.

Net Profit Ratio:

The net profit ratio was -59.87% in 2016 and -10.18% in 2015. A negative net profit ratio indicates a loss, and the decrease in the ratio from 2015 to 2016 suggests a worsening financial performance.

Return on Capital Employed (ROCE):

The return on capital employed was 116.26% in 2016 and -190.22% in 2015. The significant improvement in ROCE from negative to positive values indicates better utilization of capital in generating profits in 2016.

Return on Assets (ROA):

The return on assets was -29.02% in 2016 and -4.79% in 2015, reflecting a decrease in the company 's ability to generate profit from its assets in 2016 compared to 2015.

Dividend History